1. How relevant are the drug–drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?. (19th April 2018) Authors: Cattaneo, Dario; Formenti, Tiziana; Astuti, Noemi; Meraviglia, Paola; Ridolfo, Annalisa; Gervasoni, Cristina Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 8(2018) Page Start: 2271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lack of clinically relevant interactions between bictegravir and metformin in persons with diabetes and HIV. (17th March 2021) Authors: Cattaneo, Dario; Formenti, Tiziana; Minisci, Davide; Casalini, Giacomo; Meraviglia, Paola; Gervasoni, Cristina Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 7(2021) Page Start: 1945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The prescribing cascade 3.0: a case for recreational drugs in HIV. (1st July 2020) Authors: Cattaneo, Dario; Minisci, Davide; Formenti, Tiziana; Negri, Cristina; Rizzardini, Giuliano; Gervasoni, Cristina Journal: AIDS Issue: Volume 34:Number 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Relevance of Drug–drug Interactions in Clinical Practice: The Case of Concomitant Boosted Protease Inhibitors plus Alpha-1 Blocker Administration. Issue 5 (July 2018) Authors: Gervasoni, Cristina; Resnati, Chiara; Formenti, Tiziana; Fossati, Alessandro; Minisci, Davide; Meraviglia, Paola; Cattaneo, Dario Journal: Antiviral therapy Issue: Volume 23:Issue 5(2018) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗